International Business News - Watson http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Watson Pharmaceuticals Inc. said Wednesday it has received approval to market its generic version of the 150 mg dose of antidepressant Wellbutrin XL. Watson said the Food and Drug Administration approved its Abbreviated New Drug Application for 150 mg tablets of extended-release bupropion hydrochloride, the active ingredient in Wellbutrin XL. The company intends to begin selling the drug immediately. http://www.ibtimes.com/articles/20081126/watson-says-fda-approves-its-generic-wellbutrin-xl.htm Wed, 26 Nov 2008 16:27:36 EST Watson Pharmaceuticals Inc. said Tuesday it will pay $36 million for a portfolio of generic drugs from rival Teva Pharmaceutical Industries Ltd., as that company closes its buyout of Barr Pharmaceuticals Inc. http://www.ibtimes.com/articles/20081125/watson-to-buy-teva-drugs-for-36-million.htm Tue, 25 Nov 2008 08:43:43 EST Watson Pharmaceuticals said federal health officials should make a decision on a long-lasting version of its prostate cancer drug Trelstar by third quarter 2009. http://www.ibtimes.com/articles/20081113/fda-to-review-watsons-longer-lasting-cancer-drug.htm Thu, 13 Nov 2008 18:28:59 EST Consulting firm Watson Wyatt Worldwide Inc. said Wednesday its fiscal first-quarter profit increased 2 percent due primarily to revenue growth in its benefits and technology and administration solutions groups. http://www.ibtimes.com/articles/20081105/watson-wyatt-worldwide-1q-profit-rises-2-percent.htm Wed, 05 Nov 2008 07:36:26 EST Branded and generic drug maker Watson Pharmaceuticals Inc. raised its 2008 profit guidance Wednesday, after reporting third-quarter profit growth helped by one-time gains on an asset sale and tax liability settlement. http://www.ibtimes.com/articles/20081029/watson-increases-2008-profit-guidance-range.htm Wed, 29 Oct 2008 10:44:41 EDT Branded and generic drug maker Watson Pharmaceuticals Inc. said Wednesday its third-quarter profit more than doubled on a mix of a favorable tax liability settlement and asset sale. http://www.ibtimes.com/articles/20081029/watson-pharma-3q-profit-rises-on-settlement-sale.htm Wed, 29 Oct 2008 09:51:33 EDT Watson Pharmaceuticals Inc. is suing Barr Pharmaceuticals Inc. to prevent Barr from selling a generic version of the Oxytrol overactive bladder patch, Watson said Friday. http://www.ibtimes.com/articles/20081024/watson-files-oxytrol-patent-suit-against-barr.htm Fri, 24 Oct 2008 09:20:23 EDT Watson Pharmaceuticals Inc. said late Wednesday the Food and Drug Administration approved its drug Rapaflo for the treatment of urinary problems. The drug is approved as a treatment for BPH, or benign prostatic hyperplasia, which has symptoms including decreased urine flow and more frequent urination. http://www.ibtimes.com/articles/20081009/watson-gets-fda-approval-for-bph-drug.htm Thu, 09 Oct 2008 07:56:46 EDT Watson Pharmaceuticals Inc. on Wednesday presented updated information on the effectiveness of its experimental topical gel to treat overactive bladder syndrome. http://www.ibtimes.com/articles/20081008/watson-reports-new-data-for-bladder-drug.htm Wed, 08 Oct 2008 10:46:39 EDT Drugmaker Watson Pharmaceuticals Inc. said Wednesday the patent on its overactive bladder patch Oxytrol is being challenged. Watson said it has received a paragraph IV certification letter, which means a rival has asked the Food and Drug Administration to approve a generic version of the drug. In such challenges, filers state that the patents protecting a branded drug are invalid, unenforceable, or that a generic version won't infringe on those patents. http://www.ibtimes.com/articles/20081001/watson-says-it-received-generic-oxytrol-challenge.htm Wed, 01 Oct 2008 18:14:24 EDT Watson Pharmaceuticals Inc. on Monday reported results from four late stage trials of its drug candidate silodosin, saying the drug was well tolerated and reduced symptoms of prostate enlargement. http://www.ibtimes.com/articles/20080929/watson-pharma-prostate-drug-is-effective-safe.htm Mon, 29 Sep 2008 11:22:15 EDT _ Drug developer Watson Pharmaceuticals Inc. spent $230,000 in the second quarter to lobby on generic drug issues, federal reimbursement on prescription drugs and proposals on a system for generic biotech drugs, according to a recent disclosure report. http://www.ibtimes.com/articles/20080826/watson-spent-230-000-on-lobbying-in-2q.htm Tue, 26 Aug 2008 16:38:35 EDT Shares of Watson Wyatt Worldwide Inc. fell Wednesday after an analyst lowered his rating for the financial advisory firm, foreseeing likely curbed growth in revenue and profit. http://www.ibtimes.com/articles/20080813/watson-wyatt-shares-decline-after-downgrade.htm Wed, 13 Aug 2008 13:22:09 EDT Financial advisory firm Watson Wyatt Worldwide Inc. on Tuesday set its fiscal 2009 profit and revenue guidance mostly above Wall Street forecasts. The company expects profit between $3.70 and $3.77 on revenue between $1.85 billion and $1.9 billion. Analysts polled by Thomson Financial expect profit of $3.71 on revenue of $1.86 billion. The fiscal year ends in June. http://www.ibtimes.com/articles/20080812/watson-wyatt-outlook-mostly-above-forecasts.htm Tue, 12 Aug 2008 07:40:16 EDT Financial advisory firm Watson Wyatt Worldwide Inc. said Tuesday its profit rose 32 percent in the fiscal fourth quarter on an increase in retirement services demand and the need for investment advice. http://www.ibtimes.com/articles/20080812/watson-wyatt-4q-profit-rises-32-percent.htm Tue, 12 Aug 2008 07:38:49 EDT Branded and generic drug maker Watson Pharmaceuticals Inc. on Wednesday backed its previous fiscal-year guidance, after posting a second-quarter profit in line with Wall Street predictions. http://www.ibtimes.com/articles/20080806/watson-pharmaceuticals-backs-2008-profit-guidance.htm Wed, 06 Aug 2008 09:03:07 EDT Branded and generic drug maker Watson Pharmaceuticals Inc. said Wednesday its second-quarter profit jumped 66 percent on a gain related to a legal settlement and revenue increases at both its generic and branded divisions. http://www.ibtimes.com/articles/20080806/watson-pharmaceuticals-2q-profit-rises.htm Wed, 06 Aug 2008 08:48:55 EDT Watson Wyatt Worldwide Inc. said Monday that Roger Millay will join the consulting firm as chief financial officer, effective Aug. 18. Millay succeeds Carl Mautz, who announced his retirement in February. http://www.ibtimes.com/articles/20080721/watson-wyatt-names-new-chief-financial-officer.htm Mon, 21 Jul 2008 09:21:40 EDT Branded and generic drug maker Watson Pharmaceutical Inc. said Monday it launched a generic version of Solvay SA's Marinol, which treats chemotherapy-induced nausea. http://www.ibtimes.com/articles/20080630/watson-pharma-launches-generic-nausea-drug.htm Mon, 30 Jun 2008 12:02:09 EDT Consulting firm Watson Wyatt Worldwide Inc. said Monday it has acquired Marcu & Asociados, a Argentine human-resources and financial-services firm. Terms of the deal were not disclosed. http://www.ibtimes.com/articles/20080623/watson-wyatt-acquires-argentine-consulting-firm.htm Mon, 23 Jun 2008 15:46:23 EDT